Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flonoltinib Maleate in JAK Inhibitor-Naïve or Resistant Myelofibrosis
NCT07750574Phase 2Not yet recruiting
- Sponsor
- Zenitar
- Start
- Nov 2026
- Primary completion
- Nov 2028
01
Overview
A Phase 2 trial of flonoltinib in myelofibrosis (MF), sponsored by Zenitar. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
flonoltinib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT07750574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07750574.